Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 26.85
-0.15 (-0.56%)
Feb 11, 2026, 1:55 PM CST
Locus Cell Revenue
Locus Cell had revenue of 1.73M TWD in the quarter ending June 30, 2025, with 657.46% growth. This brings the company's revenue in the last twelve months to 5.18M, up 397.69% year-over-year. In the year 2024, Locus Cell had annual revenue of 2.36M with 480.30% growth.
Revenue (ttm)
5.18M
Revenue Growth
+397.69%
P/S Ratio
1,039.66
Revenue / Employee
97.66K
Employees
53
Market Cap
5.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.36M | 1.95M | 480.30% |
| Dec 31, 2023 | 406.00K | -194.00K | -32.33% |
| Dec 31, 2022 | 600.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.35B |
| Panion & Bf Biotech | 2.04B |
| Savior Lifetec | 1.16B |
| BioGend Therapeutics | 212.43M |
| Pharmosa Biopharm | 136.72M |
| OBI Pharma | 49.29M |
| UnicoCell Biomed | 34.58M |
| AnnJi Pharmaceutical | 23.85M |